Join in June 2025 as SAE Media Group’s renowned West Coast event returns, bringing together biotech pioneers, pharma leaders, and device innovators to shape the future of injectable drug delivery.

This year’s conference offers an unparalleled platform to explore cutting-edge advances in combination product technology while fostering collaboration between pharma, device developers, and regulators.

Why Attend?

Foster Collaboration and Innovation: Engage with industry leaders such as AstraZeneca, Gilead, and Alnylam to explore new opportunities, address challenges like large-volume delivery, and stay informed about emerging technologies.

Stay Updated on Global Regulatory Trends: Participate in discussions on evolving EU and US regulations, including the latest digital health technology registration requirements, with insights from Merck.

Optimize Combination Product Manufacturing: Learn strategies from leaders like Ionis to enhance combination product manufacturing and effectively manage product lifecycles.

Enhance Human Factors Understanding: Gain practical knowledge from JnJ and AbbVie on best practices for human factors, including testing and validation approaches for combination products.

What You’ll Gain:

Actionable insights to strengthen your drug-device portfolio.

Opportunities to network with key players shaping the injectable drug delivery landscape.

A future-focused perspective on innovation, regulation, and patient-centric care.

This must-attend event is your chance to stay ahead in the rapidly evolving injectable drug delivery space. We look forward to welcoming you to the West Coast in June 2025!

Event link here.